Targeting CD99, a surface antigen that is highly expressed on Ewing sarcoma cells, facilitates tumor localization and enhances the intracellular delivery of drug payloads, contributing to the superior antitumor activity of NV103. Here, CD99 is linked to Ewing sarcoma.